Ramsay Health Care Ltd (ASX: RHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ramsay Health Care Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $8.70 billion
P/E Ratio 36.07
Dividend Yield 1.92%
Shares Outstanding 230.25 million
Earnings per share 1.152
Dividend per share 0.80
Year To Date Return -23.89%
Earnings Yield 2.77%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Ramsay Health Care Ltd (ASX: RHC)
    Latest News

    Three cute kids with mixed expressions poke their heads out from the back of a kombi.
    Cheap Shares

    Three ASX shares down 10% to 23%! Are they cheap?

    Price doesn't equal value.

    Read more »

    Five happy young friends on the coast, dabbing and raising their arms in the air.
    Dividend Investing

    Special dividends anyone? 5 ASX 200 stocks with excess franking credits

    Investors looking for ASX dividends have long benefitted from the rules around franking credits in Australia since they were first…

    Read more »

    Cropped shot of an attractive young female scientist working on her computer in the laboratory.
    Healthcare Shares

    ASX 200 healthcare stock surges amid new takeover rumours

    Takeover rumours are circling again for this company.

    Read more »

    Smiling couple looking at a phone at a bargain opportunity.
    Healthcare Shares

    One 'oversold' ASX 200 healthcare share to buy today

    After some big share price falls, is this ASX 200 healthcare stock trading for a bargain?

    Read more »

    A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
    Share Fallers

    Why Appen, Dicker Data, Jupiter Mines, and Ramsay shares are dropping today

    These shares are ending the week in the red. But why?

    Read more »

    Shot of a senior scientist looking stressed out while working in a lab.
    Earnings Results

    Ramsay share price sinks 8% to 52-week low on disappointing FY24 results

    It was another tough year for the private hospital operator.

    Read more »

    Smiling man with phone in wheelchair watching stocks and trends on computer
    Share Market News

    5 things to watch on the ASX 200 on Friday

    Will the market end the week on a positive note? Let's find out.

    Read more »

    A man sits in front of his laptop computer with his head on his hand and a sad, dejected look on his face after seeing how far Whitehaven shares have fallen today
    Share Market News

    Here are the top 10 ASX 200 shares today

    Investors pulled back today with the markets recording a loss...

    Read more »

    Ten smiling business people wave to the camera after receiving some winning company news.
    Share Market News

    Here are the top 10 ASX 200 shares today

    It was another great day for ASX investors this Thursday.

    Read more »

    Woman disappointed at share price performance with her hands on her face.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    There was blood on the streets of the stock market today...

    Read more »

    A man looking at his laptop and thinking.
    Healthcare Shares

    Guess which ASX 100 stock is expecting to report a 200% increase in profits

    Profit guidance has been unveiled for FY 2024. Let's see what is expected.

    Read more »

    Happy man working on his laptop.
    Broker Notes

    Why the Woolworths share price could be a market beater

    Goldman Sachs thinks that investors should snap up the retail giant's shares before it's too late.

    Read more »

    Frequently Asked Questions

    Yes, Ramsay Health Care has historically paid two fully franked dividends a year.

    Ramsay Health Care generally pays its shareholder dividends in March and September. 

    Ramsay Health Care Ltd listed on the ASX on 24 September 1997.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2024 $0.4000 100.00% Final 26 Sep 2024
    11 Mar 2024 $0.4000 100.00% Interim 05 Apr 2024
    06 Sep 2023 $0.2500 100.00% Final 29 Sep 2023
    06 Mar 2023 $0.5000 100.00% Interim 30 Mar 2023
    05 Sep 2022 $0.4850 100.00% Final 29 Sep 2022
    07 Mar 2022 $0.4850 100.00% Interim 31 Mar 2022
    06 Sep 2021 $1.0300 100.00% Final 30 Sep 2021
    08 Mar 2021 $0.4850 100.00% Interim 31 Mar 2021
    05 Mar 2020 $0.6250 100.00% Interim 27 Mar 2020
    05 Sep 2019 $0.9150 100.00% Final 30 Sep 2019
    06 Mar 2019 $0.6000 100.00% Interim 29 Mar 2019
    05 Sep 2018 $0.8650 100.00% Final 28 Sep 2018
    06 Mar 2018 $0.5750 100.00% Interim 29 Mar 2018
    05 Sep 2017 $0.0000 100.00% Final 28 Sep 2017
    07 Mar 2017 $0.5300 100.00% Interim 29 Mar 2017
    06 Sep 2016 $0.7200 100.00% Final 29 Sep 2016
    08 Mar 2016 $0.4700 100.00% Interim 30 Mar 2016
    08 Sep 2014 $0.5100 100.00% Final 24 Sep 2014
    04 Mar 2014 $0.3400 100.00% Interim 26 Mar 2014
    03 Sep 2013 $0.4150 100.00% Final 25 Sep 2013
    04 Mar 2013 $0.2900 100.00% Interim 27 Mar 2013
    05 Mar 2012 $0.2550 100.00% Interim 28 Mar 2012
    02 Sep 2011 $0.2950 100.00% Final 26 Sep 2011
    08 Mar 2011 $0.2250 100.00% Interim 28 Mar 2011
    31 Aug 2010 $0.2500 100.00% Final 27 Sep 2010
    16 Mar 2010 $0.1850 100.00% Interim 09 Apr 2010
    21 Sep 2009 $0.2150 100.00% Final 09 Oct 2009
    20 Mar 2009 $0.1650 100.00% Interim 08 Apr 2009
    25 Sep 2008 $0.1750 100.00% Final 15 Oct 2008
    26 Sep 2007 $0.1600 100.00% Final 12 Oct 2007
    27 Mar 2006 $0.1050 100.00% Interim 12 Apr 2006
    26 Sep 2005 $0.1150 100.00% Final 14 Oct 2005
    16 Apr 2004 $0.0750 100.00% Interim 30 Apr 2004

    RHC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ramsay Health Care Ltd

    Ramsay Health Care Ltd (ASX: RHC) is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia. 

    As well as private hospitals, Ramsay operates day surgeries, primary care clinics, diagnostic and imaging centres, mental health facilities, pharmacies, and an expanding range of in-home and community care services.

    It is the largest private hospital group in Australia, France, and the Scandanavian countries. Its 52.5%-owned subsidiary Ramsay Sante oversees its European operations. Its UK business includes mental health facilities and a range of clinical specialties.

    The vast majority of the company's revenue is generated from its Australian and European operations.

    RHC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Nov 2024 $37.63 $-0.79 -2.06% 420,038 $38.02 $38.15 $37.63
    12 Nov 2024 $38.42 $-0.01 -0.03% 804,657 $38.47 $38.60 $38.06
    11 Nov 2024 $38.43 $-0.29 -0.75% 374,196 $38.62 $38.95 $38.38
    08 Nov 2024 $38.72 $0.32 0.83% 687,770 $38.49 $39.11 $38.20
    07 Nov 2024 $38.40 $0.12 0.31% 536,061 $38.37 $38.65 $37.97
    06 Nov 2024 $38.28 $-0.99 -2.52% 430,418 $39.68 $39.81 $38.17
    05 Nov 2024 $39.27 $-0.22 -0.56% 269,255 $39.28 $39.56 $39.10
    04 Nov 2024 $39.49 $0.21 0.53% 359,173 $39.51 $39.91 $39.26
    01 Nov 2024 $39.28 $-0.89 -2.22% 501,469 $40.05 $40.18 $39.28
    31 Oct 2024 $40.17 $-0.61 -1.50% 557,197 $40.69 $40.76 $40.11
    30 Oct 2024 $40.78 $-0.28 -0.68% 298,313 $41.00 $41.25 $40.68
    29 Oct 2024 $41.06 $-0.43 -1.04% 384,205 $41.53 $41.88 $41.06
    28 Oct 2024 $41.49 $-0.21 -0.50% 209,366 $41.70 $41.85 $41.28
    25 Oct 2024 $41.70 $-0.07 -0.17% 303,824 $41.77 $41.99 $41.43
    24 Oct 2024 $41.77 $-0.04 -0.10% 440,516 $41.63 $42.43 $41.61
    23 Oct 2024 $41.81 $0.13 0.31% 291,738 $41.70 $42.08 $41.45
    22 Oct 2024 $41.68 $-0.72 -1.70% 501,757 $42.10 $42.24 $41.67
    21 Oct 2024 $42.40 $0.04 0.09% 588,447 $42.39 $42.73 $42.25
    18 Oct 2024 $42.36 $-0.42 -0.98% 689,092 $42.77 $42.90 $42.36
    17 Oct 2024 $42.78 $0.20 0.47% 735,317 $43.10 $43.30 $42.70
    16 Oct 2024 $42.58 $-0.76 -1.75% 816,291 $42.93 $43.05 $42.51
    15 Oct 2024 $43.34 $0.67 1.57% 530,494 $42.73 $43.47 $42.73

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    05 Sep 2024 David Thodey Buy 2,475 $100,485
    On-market trade.
    04 Sep 2024 Helen Kurincic Buy 2,000 $81,159
    On-market trade.
    04 Sep 2024 Karen Penrose Buy 1,225 $49,884
    On-market trade.
    28 Aug 2024 Craig McNally Expiry 57,690 $2,532,014
    As advised by the company. Lapsed, 114,439 Rights
    22 Dec 2023 Claudia Dyckerhoff Buy 2,500 $128,275
    On-market trade.
    15 Dec 2023 Craig McNally Issued 64,625 $3,261,623
    Issue of securities. 172,129 Performance Rights
    20 Nov 2023 Karen Penrose Buy 195 $9,935
    On-market trade.
    16 Nov 2023 David Thodey Buy 4,000 $210,509
    On-market trade.
    15 Nov 2023 Karen Penrose Buy 665 $34,972
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Ingle Thodey Non-Executive DirectorNon-Executive Chairman Nov 2017
    Mr Thodey is a business leader focused on innovation, technology, digital transformation, and corporate governance, with more than 40 years of experience. In addition to being Chair of Ramsay, Mr Thodey is currently Chair of Xero Limited (a global cloud-based accounting solution for small and medium businesses). He is also Chancellor the University of Sydney, and co-Chair of the Great Barrier Reef Foundation.
    Ms Catriona Alison Deans Non-Executive Director Nov 2018
    Ms Deans has 25 years of experience building technology-enabled businesses involved in media, ecommerce, financial services, and health, and across leadership roles as an executive, a director and in venture capital. Ms Deans is also Chair of Cochlear Limited and a Non-Executive Director of Calix Limited, Fitness Passport and Deputy Pty Ltd. She is also a Venture Partner of Main Sequence Ventures.
    Mr Michael Stanley Siddle Non-Executive Director May 1975
    Mr Siddle has experience in the management of private hospitals and has been integrally involved in Ramsay Health Care's expansion through developments, mergers, and acquisitions.
    Mr Craig Ralph McNally Chief Executive OfficerManaging Director Jul 2017
    Mr McNally has worked across operational, strategic, and financial roles. For the past two decades, Mr McNally has been responsible for the development and implementation of its growth strategy including brownfield expansions, international market assessments, mergers and acquisitions and new business strategies. He has been at the forefront of all the acquisitions and deals.
    Ms Helen Kurincic Non-Executive Director Mar 2024
    Ms Kurincic brings operational, executive, and board-level experience in a range of Australian based healthcare organisations. In addition to serving on the Ramsay Board, Ms Kurincic is currently Chair of McMillan Shakespeare and a director of Carlton Football Club. Ms Kurincic's previous health sector roles include Non-Executive Director of private health insurer HBF Health, Estia Health, Integral Diagnostics (Chair), Sirtex Medical, Domain Principal Group, public hospital service provider Melbourne Health, Orygen Youth Mental Health Research Centre and DCA Group.
    Ms Karen Lee Collett Penrose Non-Executive Director Mar 2020
    Ms Penrose has had an executive career in leadership and CFO roles, mainly in financial services. She is familiar in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. She is also a member of the Risk Management Committee.
    Mr Steven Andrew Sargent Non-Executive Director Nov 2021
    Mr Sargent is Chair of the Risk Management Committee. His executive career included 22 years at General Electric, where he gained multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe and Asia Pacific. Mr Sargent is currently a Non-Executive Director of Origin Energy Limited and Chair of infection prevention company Nanosonics Limited.
    Ms Claudia Ricarda Rita Sussmuth Dyckerhoff Non-Executive Director Oct 2018
    Ms Dyckerhoff bringing expertise in market growth strategies, business development and operational performance improvement in hospitals. Dr Sussmuth Dyckerhoff has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey and Company in Switzerland in 1995 and transferred to the USA focusing on supporting health care companies, including pharmaceutical/medical device companies, payor, provider and health systems in Europe and the USA. In 2006, Dr Sussmuth Dyckerhoff transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She is also a member of the Risk Management Committee.
    Mr James Malcolm McMurdo Non-Executive Director Sep 2019
    Mr McMurdo has more than 30 years of finance and banking experience. He has a background in corporate advisory spanning across mergers and acquisitions, strategic advisory and financing with experience across multiple industries including the healthcare sector. He has held senior operating management roles and worked extensively in both the Asia Pacific and European regions. Mr McMurdo is one of the Founding Partners of Privatus Capital Partners, an advisory and merchant banking business. Prior to establishing Privatus, he held senior management roles at Deutsche Bank and was based in Hong Kong. In the time he was at Deutsche Bank, Mr McMurdo was Global Co-Head of Corporate Finance, Head of Corporate and Investment Bank for Asia Pacific and CEO for Australia and New Zealand.
    Ms Henrietta Rowe Company SecretaryGroup General Counsel Jun 2019
    -
    Henrietta Rowe Company SecretaryGroup General Counsel
    -
    Martyn Roberts Group Chief Financial Officer
    -
    Collen Harris Group Chief People Officer
    -
    Andrew Wearne Group Chief Risk Officer
    -
    Rachna Gandhi Group Chief Transformational and Digital Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 51,231,592 22.30%
    J P Morgan Nominees Australia Pty Limited 34,633,790 15.07%
    Netwealth Investments Limited <Wrap Services A/C> 23,452,113 10.21%
    Paul Ramsay Holdings Pty Limited 19,495,410 8.48%
    Citicorp Nominees Pty Limited 19,340,054 8.42%
    National Nominees Limited 4,675,258 2.04%
    Woolwich Investments Pty Ltd <The Siddle Family Trust> 2,750,000 1.20%
    BNP Paribas Noms Pty Ltd 2,655,835 1.16%
    Washington H Soul Pattinson And Company Limited 2,320,085 1.01%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 2,098,434 0.91%
    Argo Investments Limited 2,033,197 0.89%
    BNP Paribas Nominees Pty Ltd <Agency Lending Collateral > 1,663,500 0.72%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 1,645,543 0.72%
    Custodial Services Limited <Beneficiaries Holding A/C> 1,632,137 0.71%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 1,327,444 0.58%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 1,017,896 0.44%
    HSBC Custody Nominees (Australia) Limited Gsi Eda 1,000,138 0.43%
    Australian Foundation Investment Company Limited 1,000,000 0.43%
    UBS Nominees Pty Ltd 897,160 0.39%
    Certane Ct Pty Ltd <Ramsay Unallocated Ac> 778,088 0.34%

    Profile

    since

    Note